The development of the L-QoL: A quality-of-life instrument specific to systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 68, Issue 2, 2009, Pages 196-200

  Doward, L C ^a,g   McKenna, S P ^a,b   Whalley, D ^c   Tennant, A ^d   Griffiths, B ^e   Emery, P ^d   Veale, D J ^f  

^a GALEN RESEARCH   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e FREEMAN HOSPITAL   (United Kingdom)

^f ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^g Enterprise House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RASCH ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY;

ADULT; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POSTAL SERVICE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 58849130248     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.086009     Document Type: Article

References (38)

1. Johnson AE, Gordon C, Hobbs FD, Bacon PA. Undiagnosed systemic lupus erythematosus in the community. Lancet 1996;347:367-9.
2. Maddison PJ, Isenberg DA, Woo P, Glass DN. Oxford textbook of rheumatology. Oxford: Oxford University Press, 1993:733-55.
3. Karasz A, Oullette SC. Role strain and psychological well-being in women with systemic lupus erythematosus. Women Health 1995;23:41-57.
4. Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol 1999;26:504-7.
5. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 1992;22:307-19.
6. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960 (Reprinted 1980).
7. Holmes SJ, McKenna SP, Doward LC, Shalet SM. Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995;2:63-9.
8. Wagner TH, Patrick DL, McKenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996;5:443-9.
9. Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997;36:884-8.
10. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAOoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997;36:878-83.
11. Doward LC, McKenna SP, Kohlmann T, Niero M, Patrick D, Spencer B, et al. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res 1998;7:143-53.
12. McKenna SP, Doward LC, Mackenzie Davey K. The development and psychometric properties of the MSQOL; a migraine-specific quality-of-life instrument. Clin Drug Invest 1998;15:413-23.
13. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, eT al. The QoL- AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 1999;8:373- 83.
14. Doward LC, Spoorenberg A, Reynolds S, Whalley D, Helliwell PS, McKenna SP, et al. The development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6.
15. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-34.
16. Elashoff JD. NQuery advisor. version 4.0. User's guide Boston, Massachusetts: Statistical Solutions, 2000.
17. Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res 1993;2:367-8
18. Angoff WH. Perspectives on Differential Item Functioning Methodology. In: Holland PW, Wainer H, eds. Differential item functioning. Hillsdale, New Jersey: Lawrence Erlbaum, 1993.
19. European Group for Quality of Life Assessment and Hearth Measurement European guide to the Nottingham Health Profile Brookwood. Surrey: Brookwood Medical Publications, 1993.
20. Smith EV. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002,3:205-31
21. Nunally JC Jr. Psychometric theory. (2nd edn). New York: McGraw-Hill. 1978
22. Weiner E, Stewart B. Assessing individuals. Boston: Little Brown, 1984.
23. Nuremberg Doctors' Trial. Declaration of Helsinki (1964). BMJ 1996;313:1448-9
24. Larson R. Thirty years of research on the subjective well being of older Americans J Gerontol 1978;33:109-25.
25. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996;5:190-5.
26. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol 1999;26:490-7.
27. Stamm TA, Bauernfeind B, Coenen M, Feierl E. Mathis M. Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status Arthritis Rheum 2007;57:1287-95.
28. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Arthritis Rheum 1989;32:1107-18.
29. Bombardier C, Gladman DD, Urowitz MB, Charron D, Chang CH, The Committee on Prognosis Studies in SLE. The development and validation of the SLE disease activity index (SLEDAI). Arthritis Rheum 1992;35:630-40.
30. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58.
31. Vrtali C, Bencivelli W, Mosca M, Carrai P. Sereni M, Bombardieri S. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. J Rheumatol 1999;26:498-501.
32. Leong KP, Kong KO, Thong BYH, Koh ET, Lian TY, Teh CL, et al Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 2005;44:1267-76
33. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al Development and validation of a health-related quality of life measure, the LupusQoL. for adults with systemic lupus erythematosus. Arthritis Rheum 2007;57:972-9.
34. Tennant A, Conaghan PG. The Rasch Measurement Model in Rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007;57:1358-62.
35. Streiner D, Norman G. Health measurement scales. Oxford: Oxford University Press. 1989.
36. Wolfe EW. Equating and item banking with the Rasch model. J Appl Meas 2000;1:409-34.
37. McKenna SP, Doward L, Whalley D, Tennant A, Emery P, Veale D. The Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis Ann Rheum Dis 2004;63:162-9.
38. Gilworth G, Chamberlain MA, Bhakta B, Silman A, Haskard D, Tennant A. The development of the BD-Qol: a quality of life instrument specific to Behcet's disease J Rheum 2004;31:931-7.